Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,263
in 2 filings

Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-08-05 WHITFIELD ROY A Director Exercise or conversion +12,500 $11.41 $143K 32,500
2013-08-05 WHITFIELD ROY A Director Sale −12,500 $12.41 $155K 20,000
2013-08-05 WHITFIELD ROY A Director Exercise or conversion · Stock Option −12,500 0
2013-02-06 Thomsen Jillian B. VP & Chief Accounting Officer Grant or award · Stock Option +37,500 37,500
2013-02-06 Thomsen Jillian B. VP & Chief Accounting Officer Grant or award · Stock Option +37,500 37,500
2013-02-06 Hora Maninder SVP Pharma Dev and Mfg Grant or award · Stock Option +50,000 50,000
2013-02-06 Hora Maninder SVP Pharma Dev and Mfg Grant or award · Stock Option +50,000 50,000
2013-02-06 Medve Robert Chief Medical Officer Grant or award · Stock Option +50,000 50,000
2013-02-06 Medve Robert Chief Medical Officer Grant or award · Stock Option +50,000 50,000
2013-02-06 Ghosh Rinko Chief Business Officer Grant or award · Stock Option +50,000 50,000
2013-02-06 Ghosh Rinko Chief Business Officer Grant or award · Stock Option +50,000 50,000
2013-02-06 Doberstein Stephen K Chief Scientific Officer Grant or award · Stock Option +50,000 50,000
2013-02-06 Doberstein Stephen K Chief Scientific Officer Grant or award · Stock Option +50,000 50,000
2013-02-06 Nicholson John SVP & Chief Financial Officer Grant or award · Stock Option +92,500 92,500
2013-02-06 Nicholson John SVP & Chief Financial Officer Grant or award · Stock Option +92,500 92,500
2013-02-06 Labrucherie Gil M SVP & General Counsel Grant or award · Stock Option +75,000 75,000
2013-02-06 Labrucherie Gil M SVP & General Counsel Grant or award · Stock Option +75,000 75,000
2013-02-06 ROBIN HOWARD W President & CEO Grant or award · Stock Option +225,000 225,000
2013-02-06 ROBIN HOWARD W President & CEO Grant or award · Stock Option +225,000 225,000
2013-02-01 GREER R SCOTT Director Exercise or conversion +7,500 50,833

Page 68 of 69 · 1,361 trades